198 related articles for article (PubMed ID: 26433158)
1. Mining the coding and non-coding genome for cancer drivers.
Li J; Drubay D; Michiels S; Gautheret D
Cancer Lett; 2015 Dec; 369(2):307-15. PubMed ID: 26433158
[TBL] [Abstract][Full Text] [Related]
2. A Dual Model for Prioritizing Cancer Mutations in the Non-coding Genome Based on Germline and Somatic Events.
Li J; Poursat MA; Drubay D; Motz A; Saci Z; Morillon A; Michiels S; Gautheret D
PLoS Comput Biol; 2015 Nov; 11(11):e1004583. PubMed ID: 26588488
[TBL] [Abstract][Full Text] [Related]
3. Identification of coding and non-coding mutational hotspots in cancer genomes.
Piraino SW; Furney SJ
BMC Genomics; 2017 Jan; 18(1):17. PubMed ID: 28056774
[TBL] [Abstract][Full Text] [Related]
4. Prioritization of non-coding disease-causing variants and long non-coding RNAs in liver cancer.
Li H; He Z; Gu Y; Fang L; Lv X
Oncol Lett; 2016 Nov; 12(5):3987-3994. PubMed ID: 27895760
[TBL] [Abstract][Full Text] [Related]
5. Using FunSeq2 for Coding and Non-Coding Variant Annotation and Prioritization.
Dhingra P; Fu Y; Gerstein M; Khurana E
Curr Protoc Bioinformatics; 2017 May; 57():15.11.1-15.11.17. PubMed ID: 28463398
[TBL] [Abstract][Full Text] [Related]
6. Comparison of different functional prediction scores using a gene-based permutation model for identifying cancer driver genes.
Nono AD; Chen K; Liu X
BMC Med Genomics; 2019 Jan; 12(Suppl 1):22. PubMed ID: 30704472
[TBL] [Abstract][Full Text] [Related]
7. CNCDatabase: a database of non-coding cancer drivers.
Liu EM; Martinez-Fundichely A; Bollapragada R; Spiewack M; Khurana E
Nucleic Acids Res; 2021 Jan; 49(D1):D1094-D1101. PubMed ID: 33095860
[TBL] [Abstract][Full Text] [Related]
8. Candidate Cancer Driver Mutations in Distal Regulatory Elements and Long-Range Chromatin Interaction Networks.
Zhu H; Uusküla-Reimand L; Isaev K; Wadi L; Alizada A; Shuai S; Huang V; Aduluso-Nwaobasi D; Paczkowska M; Abd-Rabbo D; Ocsenas O; Liang M; Thompson JD; Li Y; Ruan L; Krassowski M; Dzneladze I; Simpson JT; Lupien M; Stein LD; Boutros PC; Wilson MD; Reimand J
Mol Cell; 2020 Mar; 77(6):1307-1321.e10. PubMed ID: 31954095
[TBL] [Abstract][Full Text] [Related]
9. IDENTIFY CANCER DRIVER GENES THROUGH SHARED MENDELIAN DISEASE PATHOGENIC VARIANTS AND CANCER SOMATIC MUTATIONS.
Ma M; Wang C; Glicksberg BS; Schadt EE; Li SD; Chen R
Pac Symp Biocomput; 2017; 22():473-484. PubMed ID: 27896999
[TBL] [Abstract][Full Text] [Related]
10. Whole-exome sequencing reveals recurrent somatic mutation networks in cancer.
Liu X; Wang J; Chen L
Cancer Lett; 2013 Nov; 340(2):270-6. PubMed ID: 23153794
[TBL] [Abstract][Full Text] [Related]
11. Computational methods and resources for the interpretation of genomic variants in cancer.
Tian R; Basu MK; Capriotti E
BMC Genomics; 2015; 16 Suppl 8(Suppl 8):S7. PubMed ID: 26111056
[TBL] [Abstract][Full Text] [Related]
12. Functional annotation of noncoding variants and prioritization of cancer-associated lncRNAs in lung cancer.
Li H; Lv X
Oncol Lett; 2016 Jul; 12(1):222-230. PubMed ID: 27347129
[TBL] [Abstract][Full Text] [Related]
13. Identification of constrained cancer driver genes based on mutation timing.
Sakoparnig T; Fried P; Beerenwinkel N
PLoS Comput Biol; 2015 Jan; 11(1):e1004027. PubMed ID: 25569148
[TBL] [Abstract][Full Text] [Related]
14. Identifying tumorigenic non-coding mutations through altered
Cheng Z; Vermeulen M; Rollins-Green M; Babak T; DeVeale B
STAR Protoc; 2021 Dec; 2(4):100934. PubMed ID: 34816127
[TBL] [Abstract][Full Text] [Related]
15. Somatic structural variation and cancer.
Tubio JM
Brief Funct Genomics; 2015 Sep; 14(5):339-51. PubMed ID: 25903743
[TBL] [Abstract][Full Text] [Related]
16. Computational analysis in cancer exome sequencing.
Evans P; Kong Y; Krauthammer M
Methods Mol Biol; 2014; 1176():219-27. PubMed ID: 25030931
[TBL] [Abstract][Full Text] [Related]
17. The search for cis-regulatory driver mutations in cancer genomes.
Poulos RC; Sloane MA; Hesson LB; Wong JW
Oncotarget; 2015 Oct; 6(32):32509-25. PubMed ID: 26356674
[TBL] [Abstract][Full Text] [Related]
18. OncodriveFML: a general framework to identify coding and non-coding regions with cancer driver mutations.
Mularoni L; Sabarinathan R; Deu-Pons J; Gonzalez-Perez A; López-Bigas N
Genome Biol; 2016 Jun; 17(1):128. PubMed ID: 27311963
[TBL] [Abstract][Full Text] [Related]
19. Interpretation of the role of germline and somatic non-coding mutations in cancer: expression and chromatin conformation informed analysis.
Pudjihartono M; Perry JK; Print C; O'Sullivan JM; Schierding W
Clin Epigenetics; 2022 Sep; 14(1):120. PubMed ID: 36171609
[TBL] [Abstract][Full Text] [Related]
20. CScape-somatic: distinguishing driver and passenger point mutations in the cancer genome.
Rogers MF; Gaunt TR; Campbell C
Bioinformatics; 2020 Jun; 36(12):3637-3644. PubMed ID: 32282885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
